News & Updates
Showing Urology articles
Showing
LHRH analogues vs tE2 patches: Which work best for prostate cancer?
The use of transdermal oestradiol (tE2) or oestrogen patches helps suppress testosterone and prostate-specific antigen (PSA) in men with locally advanced prostate cancer, with similar efficacy to that of luteinizing hormone-releasing hormone (LHRH) analogues, reports a study presented at EAU 2025.
Proteomic analysis identifies DKD progression markers in YT2D
A comprehensive analysis of circulating proteins identifies known and novel proteins associated with the progression of diabetic kidney disease (DKD) in Asians with younger-onset type 2 diabetes (YT2D; T2D onset age <40 years).
Is there a need for invasive urodynamics to manage OAB in women?
Augmenting comprehensive clinical assessment (CCA) with invasive urodynamic investigations does not appear to benefit women with refractory overactive bladder (OAB) symptoms in the FUTURE* study presented at EAU25.
Clomipramine-sildenafil combo tied to better outcomes in men with PE
The combination regimen of clomipramine and sildenafil led to better outcomes than clomipramine or sildenafil alone in men with premature ejaculation (PE) without erectile dysfunction (ED), according to a study presented at EAU25.
Anaemia in half, iron deficiency in fifth of HK patients with advanced prostate cancer
Anaemia affects 52.4 percent, while iron deficiency is present in 20.7 percent of Hong Kong patients with advanced prostate cancer (CaP), according to findings from a local cohort.
